Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Eur J Rheumatol Inflamm ; 12(2): 37-42, 1992.
Artículo en Inglés | MEDLINE | ID: mdl-1364937

RESUMEN

Thirty-nine patients with ankylosing spondylitis participated in a randomized, double-blind, double-dummy, multi-cross-over study with enteric-coated (ECT) and plain (PT) naproxen tablets. The duration of the study was 24 days with 6 treatment periods of 4 days. The majority of the patients were taking 750 mg naproxen daily. The mean plasma concentration of naproxen in the morning was 36% higher with ECT (p < 0.001). No significant differences regarding duration of morning stiffness and night time pain were found in this patient category. The mean duration of morning stiffness was 116 minutes (ECT) and 125 minutes (PT). We were not able to show correlation between plasma concentration of naproxen and duration of morning stiffness.


Asunto(s)
Naproxeno/administración & dosificación , Espondilitis Anquilosante/tratamiento farmacológico , Espondilitis Anquilosante/fisiopatología , Adolescente , Adulto , Anciano , Estudios Cruzados , Método Doble Ciego , Femenino , Humanos , Masculino , Persona de Mediana Edad , Naproxeno/efectos adversos , Naproxeno/sangre , Naproxeno/uso terapéutico , Dolor/fisiopatología , Comprimidos , Comprimidos Recubiertos
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...